Lapatinib, a TKI Dual Inhibitor of Her1 and Her2 Receptors: Review of the Literature

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations

"Lapatinib, a TKI Dual Inhibitor of Her1 and Her2 Receptors: Review of the Literature"
written by Vito Lorusso, Ilaria Marech, Marianna Giampaglia, Antonio Gnoni, Andrea Tinelli,
published by Journal of Cancer Therapy, Vol.3 No.6, 2012

has been cited by the following article(s):

[1]	La réponse antitumorale des macrophages dirigée contre les cellules de mésothéliome pleural malin
	2017

[2]	Beneficio clinico di lunga durata in paziente con carcinoma mammario metastatico HER2-positivo trattato con lapatinib e capecitabina
	2017

[3]	Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement
	Tumori Journal, 2013

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top